[D-Pro5]Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 161-164

  Edward T, Wei ^a   Thomas, Holly A ^a   Price, Jeffrey S ^b   Kishimoto, Toshimitsu ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neurobiological Technologies Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACTH (adrenocorticotropin); anti edema; CRF (corticotropin releasing factor; CRF receptor; structure activity relationship

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR 2BETA RECEPTOR; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR [20 DEXTRO GLUTAMIC ACID]; CORTICOTROPIN RELEASING FACTOR [5 DEXTROPROLINE]; CYCLIC AMP; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; CORTICOTROPIN; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CORTICOTROPIN RELEASE; GENETIC TRANSFECTION; HYPOPHYSIS CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SECOND MESSENGER; STRUCTURE ACTIVITY RELATION; THERMAL INJURY; ANIMAL; CELL LINE; DRUG POTENTIATION; EDEMA; HUMAN; SECRETION; SHEEP; SPRAGUE DAWLEY RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; EDEMA; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030582078     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00221-X     Document Type: Article

References (22)

1. Aldenhoff, J.B., D.L. Groul, J. Rivier, W. Vale and G.R. Siggins, 1983, Corticotropin-releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons, Science 221, 875.
2. Chang, C.P., R.V. Pearse, S. O'Connell and M.G. Rosenfeld, 1993, Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain, Neuron 11, 1187.
3. Chen, R., K.A. Lewis, M.H. Perrin and W.W. Vale, 1993, Expression cloning of a human corticotropin-releasing-factor receptor, Proc. Natl. Acad. Sci. USA 90, 8967.
4. Chrousos, G.P., 1995, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation, N. Engl. J. Med. 332, 1351.
5. Diamant, M. and D. de Wied, 1993, Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity, Neuroendocrinology 57, 1071.
6. Erspamer, V., G.F. Erspamer, G. Improta, L. Negri and R. de Castiglione, 1980, Sauvagine, a new polypeptide from Phyllomedusa sauvagei skin. Occurrence in various Phyllomedusa species and pharmacological actions on rat blood pressure and diuresis, Naunyn Schmiede berg's Arch. Pharmacol. 312, 265.
7. Kishimoto, T., R.V. Pearse, C.R. Lin and M.G. Rosenfeld, 1995, A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle, Proc. Natl. Acad. Sci. USA 92, 1108.
8. Kornreich, W.D., R. Galyean, J.-F. Hernandez, A.G. Craig, C.J. Donaldson, G. Yamamoto, C. Rivier, W. Vale and J. Rivier, 1992, Alanine series of ovine corticotropin-releasing factor (ovine CRF): a structure-activity relationship study, J. Med. Chem. 35, 1870.
9. Lederis, K., A. Letter, D. McMaster, G. Moore and D. Schlesinger, 1982, Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus, Science 218, 162.
10. Lei, S., R. Richter, M. Bienert and M.J. Mulvany, 1993, Relaxing actions of corticotropin-releasing factor on rat resistance arteries, Br. J. Pharmacol. 108, 941.
11. Litchfield, J.T. and F. Wilcoxon, 1949, A simplified method for evaluating dose-effect experiments, J. Pharmacol. Exp. Ther. 96, 99.
12. Lovenberg, T.W., C.W. Liaw, D.E. Grigoriadis, W. Clevenger, D.T. Chalmers, E.B. De Souza and T. Oftersdorf, 1995, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain, Proc. Natl. Acad. Sci. USA 92, 836.
13. Owens, M.J. and C.B. Nemeroff, 1991, Physiology and pharmacology of corticotropin-releasing factor, Pharmacol. Rev. 43, 425.
14. Perrin, M., C. Donaldson, R. Chen, A. Blount, T. Berggren, L. Bilezikjian, P. Sawchenko and W. Vale, 1995, Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart, Proc. Natl. Acad. Sci. USA 92, 2969.
15. Rivier, C., J. Rivier, K. Lederis and W. Vale, 1983, In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I, Regul. Pept. 5, 139.
16. Rivier, J., C. Rivier and W. Vale, 1984, Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat, Science 224, 889.
17. Rivier, J., C. Rivier, R. Galyean, A. Miranda, C. Miller, A.G. Craig, G. Yamamoto, M. Brown and W. Vale, 1993, Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics, J. Med. Chem, 36, 2851.
18. Siegel, S., 1956, Nonparametric Statistics for the Behavioral Sciences (McGraw-Hill, New York), p. 202.
19. Wei, E.T. and J.G. Kiang, 1989, Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin, Eur. J. Pharmacol. 168, 81.
20. Wei, E.T. and H.A. Thomas, 1993, Anti-inflammatory peptide agonists, Annu. Rev. Pharmacol. Toxicol. 33, 91.
21. Wei, E.T. and H.A. Thomas, 1994, Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs, Eur. J. Pharmacol. 263, 319.
22. Wei, E.T., S. Serda and J.Q. Tian, 1988, Protective actions of corticotropin-releasing factor on thermal injury to rat pawskin, J. Pharmacol. Exp. Ther. 247, 1082.